{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:45:20Z","timestamp":1792813520164,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.atherosclerosissup.2017.05.032","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T20:31:06Z","timestamp":1496349066000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pleiotropic effects of regular lipoprotein-apheresis"],"prefix":"10.1016","volume":"30","author":[{"given":"Helmut","family":"Sinzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Derfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib1","first-page":"140","article-title":"Circulating endothelial cells as a sign of vessel wall lesions","volume":"27","author":"Hladovec","year":"1978","journal-title":"Physiol Bohemoslov"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib2","first-page":"84","article-title":"Effect of high and low-dose aspirin on circulating endothelial cells","volume":"17","author":"Sinzinger","year":"1988","journal-title":"Vasa"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib3","first-page":"123","article-title":"Radioidine therapy temporarily increases circulating endothelial cells and decreases endothelial progenitor cells","volume":"6","author":"Palumbo","year":"2003","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.atherosclerosis.2004.08.036","article-title":"Acute inflammatory state during influenza infection and endothelial function","volume":"178","author":"Marchesi","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000046750","article-title":"Postprandial endothelial impairment and reduced glutathione levels in postmenopausal women","volume":"46","author":"Siepi","year":"2002","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib6","first-page":"315","article-title":"Lipid lowering therapy (simvastatin, LDL-apheresis) improves left ventricular ejection fraction","volume":"31","author":"Palumbo","year":"2004","journal-title":"Eur J Nucl Med Molec Imaging"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0021-9150(00)00415-9","article-title":"Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men","volume":"153","author":"Marchesi","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0021-9150(96)05998-9","article-title":"Peripheral vasoactivity in familial hypercholesterolemic subjects treated with heparin-induced extracorporeal LDL precipitation (HELP)","volume":"128","author":"Stadler","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jca.20000","article-title":"Improvement of endothelium-dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia","volume":"19","author":"Igarashi","year":"2004","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib11","first-page":"4613202","article-title":"Single low-density lipoprotein apheresis does not improve vascular endothelial function in chronically treated hypercholesterolemic patients","volume":"2016","author":"Ballard","year":"2016","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0049-3848(96)00079-5","article-title":"Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis","volume":"82","author":"Sinzinger","year":"1996","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1744-9987.2009.00667.x","article-title":"Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress\/rest perfusion magnetic resonance imaging","volume":"13","author":"Bohl","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/BF00190741","article-title":"The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study","volume":"72","author":"Waidner","year":"1994","journal-title":"Clin Investig"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jca.20256","article-title":"Hematologic and hemostatic changes induced by different columns during LDL apheresis","volume":"25","author":"Hovland","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jca.20006","article-title":"Effect of different LDL-apheresis methods on parameters involved in atherosclerosis","volume":"19","author":"Hershcovici","year":"2004","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosissup.2012.10.011","article-title":"Homocysteine in lipoprotein apheresis patients\u2013retrospective data analysis in apheresis center of a university hospital","volume":"14","author":"Tselmin","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jca.10010","article-title":"The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1","volume":"17","author":"Empen","year":"2002","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jca.21406","article-title":"Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia","volume":"31","author":"Drouin-Chartier","year":"2016","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1526-0968.2002.00405.x","article-title":"Influence of single low-density lipoprotein apheresis on the adhesion molecules soluble vascular cellular adhesion molecule-1, soluble intercellular adhesion molecule-1, and P-selectin","volume":"6","author":"Pulawski","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib21","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cca.2006.09.026","article-title":"Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis","volume":"377","author":"Utsumi","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosissup.2012.10.013","article-title":"Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cells","volume":"14","author":"Morawietz","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1567-5688(09)71812-4","article-title":"Impact of LDL-apheresis on inflammation and microcirculation","volume":"10","author":"Koziolek","year":"2009","journal-title":"Atherosler Suppl"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jca.21298","article-title":"Plaque regression and progenitor cell mobilization with intensive lipid elimination regimen (PREMIER) trial design","volume":"29","author":"Banerjee","year":"2014","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1194\/jlr.M500507-JLR200","article-title":"Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase","volume":"47","author":"Ma","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1159\/000314650","article-title":"Effect of low-density lipoprotein apheresis on circulating endothelial progenitor cells in familial hypercholesterolemia","volume":"29","author":"Ramunni","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jca.20208","article-title":"LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence","volume":"24","author":"Patschan","year":"2009","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2016.01.005","article-title":"The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis","volume":"105","author":"Zhang","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib29","first-page":"PI88","article-title":"Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance","volume":"9","author":"Sinzinger","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib30","first-page":"223","article-title":"LDL-apheresis improves microalbuminuria in patients with severe familial heterozygous hyoercholesterolemia","volume":"143","author":"Sinzinger","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2017.05.032_bib31","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1159\/000108634","article-title":"Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment","volume":"27","author":"Morimoto","year":"2007","journal-title":"Am J Nephrol"}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568817300740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568817300740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T07:10:37Z","timestamp":1535785837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568817300740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":31,"alternative-id":["S1567568817300740"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.05.032","relation":{},"ISSN":["1567-5688"],"issn-type":[{"value":"1567-5688","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pleiotropic effects of regular lipoprotein-apheresis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Supplements","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2017.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}